Back to top

[ Skip to main content ]

Date published: 22nd July 2006 | Type: Media release

The New Zealand Drug Foundation today released its policy on medicinal cannabis, supporting the medical use of cannabis under a trial regime.

The policy urges the Government to implement a 'compassionate regime' to allow the use of cannabis in limited circumstances.

"The evidence from around the world is now well-enough established to show that cannabis does have a therapeutic value in treating certain medical conditions," said Drug Foundation executive director Ross Bell.

"The government should lay the policy groundwork to initiate a compassionate regime, to allow patients to use cannabis when it is recommended by an approved medical practitioner.

"Cannabis is being shown to be effective at treating a range of conditions, from chronic pain, neurological disorders like multiple sclerosis, chemotherapy side-effects such as nausea and vomiting and helps stimulate appetites.

"In addition, cannabis lacks many of the side-effects of currently available medications, and often people are prescribed even more drugs to alleviate the side-effects. The government must seriously consider the benefits of medicinal cannabis."

Mr Bell said that the Drug Foundation policy was cautious about the adverse effects of smoking cannabis, but until other treatments such as cannabis-derivative sprays became available it was the best delivery method for cannabinoids.

"Let's be clear on this," said Mr Bell. "This is not a backdoor for decriminalisation of cannabis, these are entirely separate issues. We are only interested in providing a compassionate form of pain relief for thousands of New Zealanders.

"Although there is the legislative ability for the Health minister to approve the use of cannabis on an individual basis, this has never happened. Our policy would establish a tightly-controlled regime to investigate each individual's circumstances."

The Drug Foundation's policy would establish an Expert Advisory Committee on Medicinal Cannabis, which would monitor the evidence and research, and evaluate the effectiveness of the compassionate regime after a three-to-five year period.

Check out these related articles: See more articles

Medicinal cannabis law is a win for patients

Legal access to safe and affordable medicinal cannabis is a good thing for patients and carers. We remain critical about parts of the law, b......

Read More

Statement on government’s updated medicinal cannabis bill

Useful changes to the government’s medicinal cannabis bill were announced today, but the Drug Foundation says many patients will be disappoi......

Read More

Medicinal cannabis: What now?

Members of both Government and Opposition parties have let patients down by failing to reach an agreement on medicinal cannabis. So what now......

Read More
mos july 2018 tincture thumbnail

Viewpoints: Medicinal cannabis paradigms, part 2

Dr Sam McBride counters that the evidence isn’t all that compelling and that the risks are not yet fully clear – despite the naïve naturalis......

Read More
Share:
e substance newsletter promotional thumbnail
Subscribe to email updates

Get regular news, analysis and commentary on drugs issues in New Zealand. Free.

Sign up now!

Did You Know resources thumbnail
Talk drugs with young people

Did You Know helps you talk with a young person about drugs -- videos, posters and conversation starter.

Get started